OraSure Technologies (OSUR) ROIC: History & Chart

Name: OraSure Technologies, Inc. (OSUR) Return on Invested Capital (ROIC) — historical time series
Creator: TGMCharts

Compare

OraSure Technologies, Inc.(OSUR)

Medical - Instruments & Supplies · Bethlehem, PA

$3.86-0.26 (-6.20%)

Delayed quote: Oct 6, 2026, 12:54 PM EDT

Compare

About OraSure Technologies, Inc.

OraSure Technologies, Inc. and its affiliates are a global leader in the development, production, and commercialization of advanced oral fluid diagnostic solutions and specialized specimen collection tools, serving markets across the United States, Europe, and other international regions. The company operates through two primary divisions: Diagnostics and Molecular Solutions. Its diverse Diagnostics portfolio features a range of crucial offerings, such as the InteliSwab rapid tests for COVID-19 (including professional and prescription versions). It also provides several OraQuick rapid tests, encompassing solutions for HIV (Rapid, In-Home, and Self-Test versions), Hepatitis C (HCV rapid antibody), and Ebola (rapid antigen). Further diagnostic tools include the OraSure oral fluid collection device, utilized for HIV-1 antibody screening and confirmation; the Intercept drug testing systems; various immunoassay tests and reagents; and the Q.E.D. saliva alcohol test. Within its Molecular Solutions segment, OraSure offers an array of genomic products, notably under the Oragene and ORAcollect brand names, alongside specialized microbiome collection solutions and comprehensive GenoFIND genomics laboratory services. The company also supplies collection devices like ORAcollect, RNA, OMNIgene, and RAL, specifically designed for COVID-19 molecular testing. Another key offering is the Colli-Pee device, engineered for the precise volumetric collection of first-void urine. Furthermore, OraSure produces and distributes advanced kits for the collection, stabilization, transportation, and storage of genetic material samples, critical for molecular testing in diverse fields such as academic research, commercial applications (including ancestry, disease risk management, lifestyle analysis), and animal testing. Complementing these, it also provides various other diagnostic tools, including immunoassays and in vitro diagnostic tests. OraSure's sophisticated products and services are distributed to a wide array of clients, including clinical laboratories, hospitals, clinics, various community and public health organizations, wholesale distributors, governmental bodies, medical practices, and a broad spectrum of commercial and industrial entities. Established in 2000, OraSure Technologies, Inc. maintains its corporate headquarters in Bethlehem, Pennsylvania.

Bethlehem, PA

500 employees

www.orasure.com

Healthcare / Medical - Instruments & Supplies

Sector: Healthcare
Industry: Medical - Instruments & Supplies
CEO: Carrie Eglinton Manner

View full financials

OSUR Return on Invested Capital (ROIC) Metrics

RETURN ON INVESTED CAPITAL (ROIC)

-15.00%

RETURN ON INVESTED CAPITAL (ROIC) AVG TTM

-16.75%

RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y

-4.48%

RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y

-3.89%

RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y

1.17%

RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y

-0.97%

RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y

-1.76%

CURRENT VS TTM AVG

+10.50%

CURRENT VS 3Y AVG

-235.01%

CURRENT VS 5Y AVG

-285.12%

CURRENT VS 10Y AVG

-1385.83%

CURRENT VS 15Y AVG

-1453.70%

CURRENT VS 20Y AVG

-752.19%

SECTOR MEDIAN · HEALTHCARE

-34.44%

median of 760 covered companies

CURRENT VS SECTOR MEDIAN

+56.45%

vs the sector median at left

NAME	MARKET CAP	RETURN ON INVESTED CAPITAL (ROIC)	TTM	3Y	5Y
OraSure Technologies, Inc. (OSUR)	$265.41M	-15.00%	-16.75%	-4.48%	-3.89%
Eupraxia Pharmaceuticals Inc. (EPRX)vs ›	$264.83M	-43.56%	-66.27%	-114.94%	-104.61%
Inhibikase Therapeutics, Inc. (IKT)vs ›	$265.39M	-42.92%	-30.10%	-80.25%	-64.52%
EyePoint Pharmaceuticals, Inc. (EYPT)vs ›	$267.03M	-170.19%	-56.97%	-50.85%	-45.83%
Lexeo Therapeutics, Inc. Common Stock (LXEO)vs ›	$262.45M	-39.76%	-63.41%	-63.96%	-51.83%
Palisade Bio, Inc. (PALI)vs ›	$261.24M	-28.96%	-103.16%	-110.30%	-171.09%
AC Immune S.A. (ACIU)vs ›	$260.96M	-89.43%	-77.88%	-57.02%	-48.01%
Scribe Therapeutics Inc. (SCTX)vs ›	$269.11M	N/A	N/A	N/A	N/A
X4 Pharmaceuticals, Inc. (XFOR)vs ›	$259.38M	-37.61%	-32.44%	-54.09%	-56.96%
Rocket Pharmaceuticals, Inc. (RCKT)vs ›	$272.62M	-48.92%	-66.11%	-56.53%	-47.58%

NAME

MARKET CAP

RETURN ON INVESTED CAPITAL (ROIC)

TTM

OraSure Technologies, Inc. (OSUR)

$265.41M

-15.00%

-16.75%

-4.48%

-3.89%

Eupraxia Pharmaceuticals Inc. (EPRX)vs ›

$264.83M

-43.56%

-66.27%

-114.94%

-104.61%

Inhibikase Therapeutics, Inc. (IKT)vs ›

$265.39M

-42.92%

-30.10%

-80.25%

-64.52%

EyePoint Pharmaceuticals, Inc. (EYPT)vs ›

$267.03M

-170.19%

-56.97%

-50.85%

-45.83%

Lexeo Therapeutics, Inc. Common Stock (LXEO)vs ›

$262.45M

-39.76%

-63.41%

-63.96%

-51.83%

Palisade Bio, Inc. (PALI)vs ›

$261.24M

-28.96%

-103.16%

-110.30%

-171.09%

AC Immune S.A. (ACIU)vs ›

$260.96M

-89.43%

-77.88%

-57.02%

-48.01%

Scribe Therapeutics Inc. (SCTX)vs ›

$269.11M

N/A

X4 Pharmaceuticals, Inc. (XFOR)vs ›

$259.38M

-37.61%

-32.44%

-54.09%

-56.96%

Rocket Pharmaceuticals, Inc. (RCKT)vs ›

$272.62M

-48.92%

-66.11%

-56.53%

-47.58%

Return on Invested Capital (ROIC) Formula & Definition

ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)

Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.

Return on Invested Capital (ROIC) FAQ

What is the return on invested capital (ROIC) for OraSure Technologies, Inc. (OSUR)?

The return on invested capital (ROIC) for OSUR stock is -15.00%.

Is OraSure Technologies, Inc.'s return on invested capital (ROIC) high or low?

The return on invested capital (ROIC) of -15.00% is 285% below its 5-year average of -3.89%, near the low end of its 5-year range (-20.51%–11.71%).

What is the TTM average return on invested capital (ROIC) for OraSure Technologies, Inc. (OSUR)?

The TTM average return on invested capital (ROIC) for OSUR stock is -16.75%.

What is the 3Y average return on invested capital (ROIC) for OraSure Technologies, Inc. (OSUR)?

The 3Y average return on invested capital (ROIC) for OSUR stock is -4.48%.

What is the 5Y average return on invested capital (ROIC) for OraSure Technologies, Inc. (OSUR)?

The 5Y average return on invested capital (ROIC) for OSUR stock is -3.89%.

What is the 10Y average return on invested capital (ROIC) for OraSure Technologies, Inc. (OSUR)?

The 10Y average return on invested capital (ROIC) for OSUR stock is 1.17%.

What is the 15Y average return on invested capital (ROIC) for OraSure Technologies, Inc. (OSUR)?

The 15Y average return on invested capital (ROIC) for OSUR stock is -0.97%.

What is the 20Y average return on invested capital (ROIC) for OraSure Technologies, Inc. (OSUR)?

The 20Y average return on invested capital (ROIC) for OSUR stock is -1.76%.

DATE	RETURN ON INVESTED CAPITAL (ROIC)
2026-06-30	-15.00%
2026-03-31	-20.51%
2025-12-31	-18.75%
2025-09-30	-16.41%
2025-06-30	-13.11%
2025-03-31	-8.22%
2024-12-31	-4.62%
2024-09-30	-0.26%
2024-06-30	4.35%
2024-03-31	3.08%
2023-12-31	9.45%
2023-09-30	11.71%
2023-06-30	10.08%
2023-03-31	9.00%
2022-12-31	-1.40%
2022-09-30	-8.06%
2022-06-30	-13.74%
2022-03-31	-9.86%
2021-12-31	-2.96%
2021-09-30	0.56%
2021-06-30	2.89%
2021-03-31	1.38%
2020-12-31	-1.53%
2020-09-30	-1.91%
2020-06-30	-1.64%
2020-03-31	0.93%
2019-12-31	2.22%
2019-09-30	4.47%
2019-06-30	6.55%
2019-03-31	6.99%
2018-12-31	8.50%
2018-09-30	7.67%
2018-06-30	7.24%
2018-03-31	7.62%
2017-12-31	7.93%
2017-09-30	7.84%
2017-06-30	8.42%
2017-03-31	8.50%
2016-12-31	10.32%
2016-09-30	9.25%
2016-06-30	7.15%
2016-03-31	6.15%
2015-12-31	4.54%
2015-09-30	0.47%
2015-06-30	0.25%
2015-03-31	0.28%
2014-12-31	-2.94%
2014-09-30	2.31%
2014-06-30	0.54%
2014-03-31	-4.52%
2013-12-31	-7.36%
2013-09-30	-15.34%
2013-06-30	-15.93%
2013-03-31	-14.15%
2012-12-31	-9.31%
2012-09-30	-5.79%
2012-06-30	-10.52%
2012-03-31	-0.14%
2011-12-31	-8.30%
2011-09-30	-0.13%
2011-06-30	-5.11%
2011-03-31	-3.43%
2010-12-31	-3.03%
2010-09-30	-5.25%
2010-06-30	-3.94%
2010-03-31	-8.28%
2009-12-31	-7.84%
2009-09-30	-10.12%
2009-06-30	-14.93%
2009-03-31	-13.08%
2008-12-31	-13.93%
2008-09-30	-7.88%
2008-06-30	-6.10%
2008-03-31	-2.34%
2007-12-31	-0.47%
2007-09-30	0.38%
2007-06-30	1.75%
2007-03-31	2.04%
2006-12-31	2.26%
2006-09-30	4.94%
2006-06-30	5.60%
2006-03-31	5.93%
2005-12-31	6.29%
2005-09-30	5.45%
2005-06-30	1.44%
2005-03-31	0.23%
2004-12-31	-1.74%
2004-09-30	-0.51%
2004-06-30	0.02%
2004-03-31	-0.63%
2003-12-31	-1.66%
2003-09-30	-5.57%
2003-06-30	-7.27%

DATE

RETURN ON INVESTED CAPITAL (ROIC)

2026-06-30

-15.00%

2026-03-31

-20.51%

2025-12-31

-18.75%

2025-09-30

-16.41%

2025-06-30

-13.11%

2025-03-31

-8.22%

2024-12-31

-4.62%

2024-09-30

-0.26%

2024-06-30

4.35%

2024-03-31

3.08%

2023-12-31

9.45%

2023-09-30

11.71%

2023-06-30

10.08%

2023-03-31

9.00%

2022-12-31

-1.40%

2022-09-30

-8.06%

2022-06-30

-13.74%

2022-03-31

-9.86%

2021-12-31

-2.96%

2021-09-30

0.56%

2021-06-30

2.89%

2021-03-31

1.38%

2020-12-31

-1.53%

2020-09-30

-1.91%

2020-06-30

-1.64%

2020-03-31

0.93%

2019-12-31

2.22%

2019-09-30

4.47%

2019-06-30

6.55%

2019-03-31

6.99%

2018-12-31

8.50%

2018-09-30

7.67%

2018-06-30

7.24%

2018-03-31

7.62%

2017-12-31

7.93%

2017-09-30

7.84%

2017-06-30

8.42%

2017-03-31

8.50%

2016-12-31

10.32%

2016-09-30

9.25%

2016-06-30

7.15%

2016-03-31

6.15%

2015-12-31

4.54%

2015-09-30

0.47%

2015-06-30

0.25%

2015-03-31

0.28%

2014-12-31

-2.94%

2014-09-30

2.31%

2014-06-30

0.54%

2014-03-31

-4.52%

2013-12-31

-7.36%

2013-09-30

-15.34%

2013-06-30

-15.93%

2013-03-31

-14.15%

2012-12-31

-9.31%

2012-09-30

-5.79%

2012-06-30

-10.52%

2012-03-31

-0.14%

2011-12-31

-8.30%

2011-09-30

-0.13%

2011-06-30

-5.11%

2011-03-31

-3.43%

2010-12-31

-3.03%

2010-09-30

-5.25%

2010-06-30

-3.94%

2010-03-31

-8.28%

2009-12-31

-7.84%

2009-09-30

-10.12%

2009-06-30

-14.93%

2009-03-31

-13.08%

2008-12-31

-13.93%

2008-09-30

-7.88%

2008-06-30

-6.10%

2008-03-31

-2.34%

2007-12-31

-0.47%

2007-09-30

0.38%

2007-06-30

1.75%

2007-03-31

2.04%

2006-12-31

2.26%

2006-09-30

4.94%

2006-06-30

5.60%

2006-03-31

5.93%

2005-12-31

6.29%

2005-09-30

5.45%

2005-06-30

1.44%

2005-03-31

0.23%

2004-12-31

-1.74%

2004-09-30

-0.51%

2004-06-30

0.02%

2004-03-31

-0.63%

2003-12-31

-1.66%

2003-09-30

-5.57%

2003-06-30

-7.27%

Return on Invested Capital (ROIC): -15.00%

OSUR Return on Invested Capital (ROIC)

OSUR Average Return on Invested Capital (ROIC) Chart

OSUR Current vs Average Return on Invested Capital (ROIC) Chart

OSUR Return on Invested Capital (ROIC) Metrics

OSUR Competitors' Return on Invested Capital (ROIC)

Capital Efficiency

Return on Invested Capital (ROIC) Formula & Definition

Return on Invested Capital (ROIC) FAQ

OSUR Return on Invested Capital (ROIC) History

Related Metrics